HOOPER, LUNDY & BOOKMAN, P.C. for ROCHE DIAGNOSTICS CORPORATION
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 19, 2019 | $30,000 | Replaced |
| 2nd Quarter - Amendment | Oct 20, 2019 | $50,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2018 Discussion draft; Laboratory Access for Beneficiaries Act, H.R. 3584
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996) |
Medical/Disease Research/Clinical Labs MED
The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2018 Discussion draft; Laboratory Access for Beneficiaries Act, H.R. 3584.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.